Meeting Description:

ANCO & MOASC present Precision Oncology Symposium 2024, taking place on November 2, 2024 at the Claremont Club & Spa.
Precision oncology has the potential to enhance patient outcomes by utilizing extensive molecular diagnostic profiling and personalized treatment recommendations. 
The recent FDA approvals of novel cancer treatments that are based on molecular tumor features, rather than disease type, highlight the importance  of this approach.
However, the landscape of available diagnostic technologies and targeted drugs is constantly evolving, making it challenging for practicing  oncologists and related professionals to remain up-to-date and provide their patients with the most effective molecular diagnostic approach.
By attending this meeting, clinicians will be informed about the latest cutting-edge technologies and their optimal clinical applications.

Learning Objectives: 
•    Identify the challenges associated with implementing precision oncology in clinical practice.
•    Recognize the opportunities and current limitations presented by precision oncology in improving patient outcomes and personalized treatment approaches.
•    Assess the potential impact of new technologies on improving the accuracy and utility of liquid biopsy diagnostics.
•    Develop strategies for effective collaboration between patient advocates and healthcare professionals in advancing precision oncology.
•    Discuss the role of precision medicine in early diagnosis and screenings.

Hotel Information - 

ANCO & MOASC have secured a discounted hotel room block for this meeting. Attendees must be registered for the meeting in order to receive the booking link Booking information will be in your registration confirmation email. The deadline to book your hotel room is October 1, 2024

Registration Link - https://cvent.me/y1ObRP